SCP
SRTA

Sender Company & Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Sender Company & Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,270
Closed -$87.4K – 147
2025
Q3 		$87.4K Buy
+17,270
New +$76.3K 0.01% 446

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Sender Company & Partners's SRTA Position: Q4 2025 in Review

Sender Company & Partners sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 17,270 shares — an estimated $87.4K sold.

Sender Company & Partners first reported a position in SRTA in Q3 2025 and held it in 1 quarter. The position peaked at $87.4K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Sender Company & Partners reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • Sender Company & Partners sold 17,270 Strata Critical Medical Inc shares in Q4 2025, an estimated $87.4K.
  • Sender Company & Partners first reported a position in Strata Critical Medical Inc in Q3 2025 and held it in 1 quarter.
  • Sender Company & Partners's Strata Critical Medical Inc position peaked at $87.4K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.